Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MBP antisense RNA 1 (MBP-AS1) is a human long non-coding RNA gene identified as an antisense transcript relative to the MBP (myelin basic protein) gene[5]. Antisense RNAs, including MBP-AS1, are typically involved in regulating gene expression of their sense (protein-coding) counterparts and may modulate biological processes such as transcription, translation, and epigenetic regulation[1][3]. While antisense RNAs in general are recognized as regulators in health and disease, MBP-AS1 itself does not have well-characterized biological functions, disease associations, or therapeutic significance as of current scientific knowledge[1][3][5].
Not applicable, as there are no known drugs targeting MBP-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MBP antisense RNA 1 (MBP-AS1).